Medicine for treating cardiovascular and cerebrovascular diseases

Abstract

The invention discloses a traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases. The composition is prepared from, by mass, 10-20 parts of aconiti preparata, 10-20 parts of prepared kusnezoff monkshood root, 10-20 parts of rhizoma sparganii, 10-20 parts of curcuma zedoary, 10-20 parts of peach kernel, 10-20 parts of pseudo-ginseng, 10-20 parts of safflower, 10-20 parts of silkworm larva, 30-60 parts of donkey-hide gelatin, 10-20 parts of dried tangerine peel, 10-20 parts of platycodon grandiflorum, 30-60 parts of astragalus, 30-60 parts of spatholobus, 15-30 parts of saggentodoxa cuneata rehd, 15-30 parts of ramulus mori, 15-30 parts of papaya, 10-20 parts of folium mri, 20-40 parts of liquidambar fruit, 15-30 parts of gastrodia, 15-30 parts of saposhnikovia divaricata, 10-20 parts of locusts, 10-20 parts of leeches, 10-20 parts of whole bats, 10-20 parts of medlar, 20-40 parts of cassia seed, 20-40 parts of salvia, 10-20 parts of ligusticumwallichii, 15-30 parts of red peony, 20-40 parts of earthworm, 10-20 parts of antelope bone, 20-40 parts of hawthorn, 10-20 parts of large-leaved gentian, 10-20 parts of radix angelicae tuhuo, 10-20 parts of radix clematidis, 15-30 parts of semiliquidambar cathayensis, 10-20 parts of arisacma consanguineum, 10-20 parts of pinellia ternata, 10-20 parts of allii macrostemi bulbus, 10-20 parts of fragrant incense, 10-20 parts of Chinese trichosanthes, 15-30 parts of motherwort, 20-40 parts of ganoderma lucidum, 15-30 parts of pueraria, 15-30 parts of sophora flower and 15-30 parts of retinervus luffae fructus.

Description

technical field [0001] The invention relates to the technical field of medicine preparation, in particular to a medicine for treating cardiovascular and cerebrovascular diseases. Background technique [0002] Cardiovascular and cerebrovascular diseases are collectively referred to as cardiovascular and cerebrovascular diseases, and generally refer to ischemic or hemorrhagic diseases of the heart, brain and systemic tissues caused by hyperlipidemia, blood viscosity, atherosclerosis, and high blood pressure. Cardiovascular and cerebrovascular diseases are a serious threat to human beings with high morbidity and mortality. Even if the most advanced and perfect treatment methods are applied, more than 50% of cerebrovascular accident survivors cannot fully take care of themselves. The number of patients with cardiovascular and cerebrovascular diseases is large, ranking first among various causes of death. Traditional western medicines have poor therapeutic effects on cardiovascu...

AI Technical Summary

Problems solved by technology

Traditional western medicines have poor therapeutic effects on cardiovascular and cerebrovascular diseases, and they treat the symptoms but not the root cause, and there are adverse reactions and side effects. It is urgent to develop a more effective drug